GSK to Shut Vaccine Factory in Germany, Putting 641 Jobs at Risk
The company said declining demand for egg-based flu vaccines led it to consolidate production at one site in Canada.
- On Friday, GSK announced it will shut down a vaccine factory in Dresden, Germany, by summer 2027, producing flu and hepatitis shots.
- Decreasing demand for traditional egg-based flu vaccines prompted GSK to consolidate operations at its site in Ste-Foy, Canada, which better matches anticipated future demand.
- The closure puts 641 jobs at risk; Industriegewerkschaft Bergbau, Chemie, Energie and the works council opposed the decision after employees were informed on Thursday.
- Closing the plant could cost Saxony highly skilled industrial jobs and deprive Germany of important pharmaceutical manufacturing expertise, the union warned.
- Separately, Volkswagen announced a restructuring plan last week that could lead to 50,000 additional job cuts worldwide, including factories in Saxony, while GSK advances an mRNA-based flu vaccine trial this month.
18 Articles
18 Articles
GSK to shut vaccine factory in Germany, putting 641 jobs at risk - Regional Media News
By Puyaan Singh and Bhanvi Satija Sept 11 (Reuters) - GSK said on Friday it will be shutting down a vaccine factory in Dresden, Germany, in the summer of 2027, citing decreasing demand for traditional egg-based flu vaccines. The closure would put 641 jobs at risk, according to German trade union Industriegewerkschaft Bergbau, Chemie, Energie (IGBCE). Here are more details: • "With decreasing demand for traditional egg-based flu vaccines, meaning…
GSK to shut vaccine factory in Germany, putting 641 jobs at risk
By Puyaan Singh and Bhanvi Satija Sept 11 (Reuters) - GSK said on Friday it will be shutting down a vaccine factory in Dresden, Germany, which its website showed produces flu and hepatitis shots, in the summer of 2027. The closure would put 641 jobs ...
The Dresden plant employs almost 650 people.
The pharmaceutical company GlaxoSmithKline wants to close its location in Dresden by the summer of 2028.
GSK produces vaccines against influenza and hepatitis. According to previous data, 2 million doses of vaccine are produced in Dresden per week.
After 115 years, vaccine production in Dresden is running out. The pharmaceutical company GlaxoSmithKline (GSK) plans to close its site with almost 650 employees by the summer of 2028.
Coverage Details
Bias Distribution
- 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
